Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab for CSC
NCT00418431Phase 3Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Apr 2006
- Primary completion
- Apr 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bevacizumab in Central Serous Chorioretinopathy (CSCR), sponsored by Asociación para Evitar la Ceguera en México. Planned start Apr 2006; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT00418431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418431.